Works matching AU Pietro, Alessandra di


Results: 13
    1

    Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.

    Published in:
    Oncologist, 2023, v. 28, n. 4, p. 333, doi. 10.1093/oncolo/oyac243
    By:
    • Larkin, James;
    • Oya, Mototsugu;
    • Martignoni, Marcella;
    • Thistlethwaite, Fiona;
    • Nathan, Paul;
    • Ornstein, Moshe C;
    • Powles, Thomas;
    • Beckermann, Kathryn E;
    • Balar, Arjun V;
    • McDermott, David;
    • Gupta, Sumati;
    • Philips, George K;
    • Gordon, Michael S;
    • Uemura, Hirotsugu;
    • Tomita, Yoshihiko;
    • Wang, Jing;
    • Michelon, Elisabete;
    • Pietro, Alessandra di;
    • Choueiri, Toni K
    Publication type:
    Article
    2

    Meeting Report from the Third Global Workshop on Melanoma.

    Published in:
    2010
    By:
    • Agarwala, Sanjiv S.;
    • Di Pietro, Alessandra;
    • Flaherty, Keith T.;
    • Garbe, Claus;
    • Grob, Jean-Jacques;
    • Kashani-Sabet, Mohammed;
    • Kirkwood, John M.;
    • Leachman, Sancy;
    • Messina, Jane;
    • O'Day, Steven;
    • Ribas, Antoni;
    • Sondak, Vernon
    Publication type:
    Report
    3
    4

    Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial.

    Published in:
    Clinical & Translational Oncology, 2024, v. 26, n. 6, p. 1532, doi. 10.1007/s12094-023-03358-4
    By:
    • Climent, Miguel Ángel;
    • Álvarez, Carlos;
    • Morales, Rafael;
    • Maroto, Pablo;
    • Rodríguez-Vida, Alejo;
    • Méndez-Vidal, María José;
    • del Muro, Xavier García;
    • Puente, Javier;
    • Láinez, Nuria;
    • Vázquez, Sergio;
    • Castellano, Daniel;
    • Lang, Carmen Gómez;
    • Wang, Jing;
    • di Pietro, Alessandra;
    • Davis, Craig;
    • Sanz-Castillo, Belén;
    • Bolós, M. Victoria;
    • Valderrama, Begoña P.
    Publication type:
    Article
    5
    6
    7
    8
    9

    Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 2, p. 383, doi. 10.1007/s10147-021-02067-8
    By:
    • Tomita, Yoshihiko;
    • Yamamoto, Yoshiaki;
    • Tsuchiya, Norihiko;
    • Kanayama, Hiroomi;
    • Eto, Masatoshi;
    • Miyake, Hideaki;
    • Powles, Thomas;
    • Yoshida, Mizuki;
    • Koide, Yuichiro;
    • Umeyama, Yoshiko;
    • di Pietro, Alessandra;
    • Uemura, Hirotsugu
    Publication type:
    Article
    10
    11

    Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach Testori et al. ECT for skin tumors.

    Published in:
    Dermatologic Therapy, 2010, v. 23, n. 6, p. 651, doi. 10.1111/j.1529-8019.2010.01370.x
    By:
    • Testori, Alessandro;
    • Tosti, Giulio;
    • Martinoli, Chiara;
    • Spadola, Giuseppe;
    • Cataldo, Francesco;
    • Verrecchia, Francesco;
    • Baldini, Federica;
    • Mosconi, Massimo;
    • Soteldo, Javier;
    • Tedeschi, Ines;
    • Passoni, Claudia;
    • Pari, Chiara;
    • Pietro, Alessandra di;
    • Ferrucci, Pier Francesco
    Publication type:
    Article
    12

    POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae033
    By:
    • Menzies, Alexander M;
    • Long, Georgina V;
    • Kohn, Amiee;
    • Tawbi, Hussein;
    • Weber, Jeffrey;
    • Flaherty, Keith;
    • McArthur, Grant A;
    • Ascierto, Paolo A;
    • Pfluger, Yanina;
    • Lewis, Karl;
    • Tsai, Katy K;
    • Hamid, Omid;
    • Prenen, Hans;
    • Fein, Luis;
    • Wang, Erjian;
    • Guenzel, Carolin;
    • Zhang, Fan;
    • Kleha, Joseph F;
    • Pietro, Alessandra di;
    • Davies, Michael A
    Publication type:
    Article
    13